Greenwich LifeSciences's current assets is $11M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), GLSI shows a current assets of $11M. That compares with $2.7M in the prior-year period — up 282.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, GLSI's current assets is now $11M (was $2.7M) — a 282.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Greenwich LifeSciences is outperforming or lagging.
Tracking GLSI's current assets over time shows whether Greenwich LifeSciences is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $2.7M in the prior-year period — up 282.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Greenwich LifeSciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $11M) with ownership activity and broader fundamentals.
Greenwich LifeSciences's current assets is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.